http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-1154678-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8c646f75c4f7c6349f35c8fe01934921 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-01 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-01 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-205 |
| filingDate | 1980-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1983-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2712fbc3311f345d75951db2e53f13c |
| publicationDate | 1983-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CA-1154678-A |
| titleOfInvention | Pharmaceutical composition for parenteral nutrition comprising l-carnitine or acyl l-carnitines |
| abstract | "Pharmaceutical composition for parenteral nutrition comprising L-carnitine or acyl L-carnitines." ABSTRACT OF THE DISCLOSURES A glucose solution for drip phleboclysis characterized by the inclusion therein of L-carnitine is disclosed. The presence of L-carnitine improves the muscle tissue absorption and utilization of glucose, thus preventing excessive insulin secretion. This permits the utilization of 10% glucose solutions, and also in excess of 10%, without any risk for the patient even in the case of long-term treatment. |
| priorityDate | 1979-10-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 127.